• Aglaris Ltd

    London; United Kingdom/Madrid; SPAIN

    Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells.
    Aglaris Cell stems from the collaboration between researchers at two institutions, the biomaterials group at Barcelona’s IQS and the group for the Regulation of the Genetic Expression and Stability of Stem Cells at a leading organization.

    www.aglariscell.es

  • BioMediTech

    Tampere; Finland

    BioMediTech, a joint institute of Tampere University of Technology and University of Tampere, brings together a powerful mix of multidisciplinary expertise in life sciences and medical technology. Over 250 scientists conduct research and education in the fields of cell and molecular biology, genetics, biomaterials, biosensors, computational systems, biotechnology, biomedical engineering, and regenerative medicine. The institute aims not only to integrate and strengthen the local tradition of excellence in basic life-science research and teaching, but also to create new platforms for discovery and innovation. 

    www.biomeditech.fi

  • Bioversys

    Basel; Switzerland

    Bioversys AG is a privately held Swiss biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Spun out of the ETH-Zurich in 2008, the company has profound technological expertise that is based on solid IP. 

    www.bioversys.com

  • Campania Bioscience Scarl

    Naples; Italy

    Campania Bioscience is a regional cluster set in Naples (Campania region – Southern Italy) gathering together competences and facilities in the fields of Health, Biotech and Agro-food, with the aim of valorising partners’ expertise in the value chain, stimulating exploitation of cluster assets, supporting knowledge transfer and encouraging international networking and partnerships.

    www.campaniabioscience.it

  • Fundación MEDINA

    Granada; Spain

    Fundación MEDINA is a non-profit research organisation with focus on drug discovery. The screening of microbial natural products will contribute to the discovery of new drugs that could meet current therapeutic needs.

    www.medinaandalucia.es

  • Leitat - Technological Center

    Terrassa; Spain

    LEITAT is a Technological Center, member of TECNIO and recognized by the Ministry of Economy and Competitiveness, that aims to collaborate with companies and institutions by adding technological value both to products and processes, and focuses its activity on research, development and industrial innovation (R+D+2i).

    www.leitat.org

  • OnTarget Chemistry

    Uppsala; Sweden

    OnTarget Chemistry – was established, initially as OncoTargeting, in 2008 as a spin-out from the medicinal chemistry, combinatorial chemistry and preclinical analysis departments of Pharmacia (Biovitrum). We have continued to employ some of the industry’s most experienced chemists and run a well-trimmed organization with solid values of service, quality and efficiency.

    Our repertoire includes a complete medicinal chemistry offering. We run all the usual synthesis and analysis services alongside more rare and demanding specialities. We are located in the former Pharmacia properties of Uppsala Business Park, Sweden with purpose-built premises and well-equipped labs.

    www.ontargetchemistry.com

  • ProtATonce

    Glyfada; Greece

    ProtATonce provides A-to-Z support in the analysis and generation of multi-omics data for drug and biomarker discovery. Our state-of-the-art facilities for tissue culture and molecular biology, the unique expertise in multiplexed proteomic and phosphoproteomic assays (Luminex assays), our advanced computational tools, and our happy customers guarantee a unique high quality service.

    www.protatonce.com

  • University of Birmingham

    Birmingham; United Kingdom

    Birmingham is constantly developing and evolving in its desire to become a leading global university. This is being achieved through the enhanced research power and reach; the distinctiveness of exceptional student experience; the breadth and depth of academic portfolio; size and extent of the global networks.

    The School of Biosciences has achieved an impressive performance in the Research Excellence Framework 2014 (REF 2014) rising up to 6th place in the Russell Group. This strong performance has been achieved through focusing on research strengths across the School, and by the recruitment of many new staff, including seven Birmingham Fellows, who have all made a big contribution to the School’s research.

    http://www.birmingham.ac.uk

Membership - Join the Network!

Individual Membership for natural persons is free, while Corporate Membership, for companies, institutions and research groups start from €500 p.a.
Click here to apply for network membership!

Address

European Biotechnology Network AISBL

Rue de la Science 14b
1040 Brussels, Belgium

Tel: +32 2 588 70 71
office@european-biotechnology.net

Website Sponsor of the Month